homehealthcare News

Drug regulator initiates probe into all Johnson and Johnson products, says report

Drug regulator initiates probe into all Johnson and Johnson products, says report

Drug regulator initiates probe into all Johnson and Johnson products, says report
Profile image

By CNBC-TV18 Dec 21, 2018 8:41:51 AM IST (Published)

Drug Controller General of India (DCGI), India's drug regulator, has initiated a wider investigation into all the baby care products of Johnson and Johnson, Mint reported, citing sources.

Recommended Articles

View All

“All other baby products will also be tested for their ingredients and preservatives. The drug inspectors have been told to start lifting the samples both from its manufacturing sites and markets all over India,” sources told the paper.
The regulator had earlier ordered a halt in the production of its talcum powder amid allegations that it contains asbestos.
The drug regulator has issued Form 15 (under the Drugs and Cosmetics Act) to J&J’s manufacturing plants in Mulund and Baddi, restricting the company from using raw material for talcum powder till further orders, the report said.
According to the report, the drug inspectors has discovered that the company was testing the raw material in violation of the Drugs and Cosmetics Act.
“Under the Act, it is mandatory to test every batch of the raw material. However, drug inspectors found that J&J was randomly testing its raw material,” official sources told the paper. “They have been issued Form 15, which means that they cannot dispose of stocks of raw material used for talc till further orders and hence cannot manufacture their talc till further orders."
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng